- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
According to our latest study, the global Hepatitis B Vaccines market size was valued at USD 1051.4 million in 2022 and is forecast to a readjusted size of USD 1184.9 million by 2029 with a CAGR of 1.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report is a detailed and comprehensive analysis for global Hepatitis B Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hepatitis B Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Hepatitis B Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Hepatitis B Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Hepatitis B Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hepatitis B Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hepatitis B Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, NCPC, Merck, Bio Kangtai and Dynavax, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hepatitis B Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Yeast Derived
CHO Derived
Market segment by Application
Children
Adult
Major players covered
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis B Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hepatitis B Vaccines, with price, sales, revenue and global market share of Hepatitis B Vaccines from 2018 to 2023.
Chapter 3, the Hepatitis B Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis B Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hepatitis B Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatitis B Vaccines.
Chapter 14 and 15, to describe Hepatitis B Vaccines sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Hepatitis B Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hepatitis B Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Yeast Derived
1.3.3 CHO Derived
1.4 Market Analysis by Application
1.4.1 Overview: Global Hepatitis B Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Children
1.4.3 Adult
1.5 Global Hepatitis B Vaccines Market Size & Forecast
1.5.1 Global Hepatitis B Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hepatitis B Vaccines Sales Quantity (2018-2029)
1.5.3 Global Hepatitis B Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Hepatitis B Vaccines Product and Services
2.1.4 GSK Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GSK Recent Developments/Updates
2.2 NCPC
2.2.1 NCPC Details
2.2.2 NCPC Major Business
2.2.3 NCPC Hepatitis B Vaccines Product and Services
2.2.4 NCPC Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 NCPC Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Hepatitis B Vaccines Product and Services
2.3.4 Merck Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 Bio Kangtai
2.4.1 Bio Kangtai Details
2.4.2 Bio Kangtai Major Business
2.4.3 Bio Kangtai Hepatitis B Vaccines Product and Services
2.4.4 Bio Kangtai Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bio Kangtai Recent Developments/Updates
2.5 Dynavax
2.5.1 Dynavax Details
2.5.2 Dynavax Major Business
2.5.3 Dynavax Hepatitis B Vaccines Product and Services
2.5.4 Dynavax Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dynavax Recent Developments/Updates
2.6 Hissen
2.6.1 Hissen Details
2.6.2 Hissen Major Business
2.6.3 Hissen Hepatitis B Vaccines Product and Services
2.6.4 Hissen Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hissen Recent Developments/Updates
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Hepatitis B Vaccines Product and Services
2.7.4 KM Biologics Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KM Biologics Recent Developments/Updates
2.8 LG Life Sciences
2.8.1 LG Life Sciences Details
2.8.2 LG Life Sciences Major Business
2.8.3 LG Life Sciences Hepatitis B Vaccines Product and Services
2.8.4 LG Life Sciences Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LG Life Sciences Recent Developments/Updates
2.9 Serum Institute
2.9.1 Serum Institute Details
2.9.2 Serum Institute Major Business
2.9.3 Serum Institute Hepatitis B Vaccines Product and Services
2.9.4 Serum Institute Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Serum Institute Recent Developments/Updates
3 Competitive Environment: Hepatitis B Vaccines by Manufacturer
3.1 Global Hepatitis B Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hepatitis B Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Hepatitis B Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hepatitis B Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hepatitis B Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Hepatitis B Vaccines Manufacturer Market Share in 2022
3.5 Hepatitis B Vaccines Market: Overall Company Footprint Analysis
3.5.1 Hepatitis B Vaccines Market: Region Footprint
3.5.2 Hepatitis B Vaccines Market: Company Product Type Footprint
3.5.3 Hepatitis B Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hepatitis B Vaccines Market Size by Region
4.1.1 Global Hepatitis B Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Hepatitis B Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Hepatitis B Vaccines Average Price by Region (2018-2029)
4.2 North America Hepatitis B Vaccines Consumption Value (2018-2029)
4.3 Europe Hepatitis B Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Hepatitis B Vaccines Consumption Value (2018-2029)
4.5 South America Hepatitis B Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Hepatitis B Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hepatitis B Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Hepatitis B Vaccines Consumption Value by Type (2018-2029)
5.3 Global Hepatitis B Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hepatitis B Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Hepatitis B Vaccines Consumption Value by Application (2018-2029)
6.3 Global Hepatitis B Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Hepatitis B Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Hepatitis B Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Hepatitis B Vaccines Market Size by Country
7.3.1 North America Hepatitis B Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Hepatitis B Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hepatitis B Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Hepatitis B Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Hepatitis B Vaccines Market Size by Country
8.3.1 Europe Hepatitis B Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Hepatitis B Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hepatitis B Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hepatitis B Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hepatitis B Vaccines Market Size by Region
9.3.1 Asia-Pacific Hepatitis B Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hepatitis B Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hepatitis B Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Hepatitis B Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Hepatitis B Vaccines Market Size by Country
10.3.1 South America Hepatitis B Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Hepatitis B Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hepatitis B Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hepatitis B Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hepatitis B Vaccines Market Size by Country
11.3.1 Middle East & Africa Hepatitis B Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hepatitis B Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hepatitis B Vaccines Market Drivers
12.2 Hepatitis B Vaccines Market Restraints
12.3 Hepatitis B Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hepatitis B Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hepatitis B Vaccines
13.3 Hepatitis B Vaccines Production Process
13.4 Hepatitis B Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hepatitis B Vaccines Typical Distributors
14.3 Hepatitis B Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Hepatitis B Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hepatitis B Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Hepatitis B Vaccines Product and Services
Table 6. GSK Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GSK Recent Developments/Updates
Table 8. NCPC Basic Information, Manufacturing Base and Competitors
Table 9. NCPC Major Business
Table 10. NCPC Hepatitis B Vaccines Product and Services
Table 11. NCPC Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. NCPC Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Hepatitis B Vaccines Product and Services
Table 16. Merck Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. Bio Kangtai Basic Information, Manufacturing Base and Competitors
Table 19. Bio Kangtai Major Business
Table 20. Bio Kangtai Hepatitis B Vaccines Product and Services
Table 21. Bio Kangtai Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bio Kangtai Recent Developments/Updates
Table 23. Dynavax Basic Information, Manufacturing Base and Competitors
Table 24. Dynavax Major Business
Table 25. Dynavax Hepatitis B Vaccines Product and Services
Table 26. Dynavax Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Dynavax Recent Developments/Updates
Table 28. Hissen Basic Information, Manufacturing Base and Competitors
Table 29. Hissen Major Business
Table 30. Hissen Hepatitis B Vaccines Product and Services
Table 31. Hissen Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hissen Recent Developments/Updates
Table 33. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 34. KM Biologics Major Business
Table 35. KM Biologics Hepatitis B Vaccines Product and Services
Table 36. KM Biologics Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KM Biologics Recent Developments/Updates
Table 38. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 39. LG Life Sciences Major Business
Table 40. LG Life Sciences Hepatitis B Vaccines Product and Services
Table 41. LG Life Sciences Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. LG Life Sciences Recent Developments/Updates
Table 43. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 44. Serum Institute Major Business
Table 45. Serum Institute Hepatitis B Vaccines Product and Services
Table 46. Serum Institute Hepatitis B Vaccines Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Serum Institute Recent Developments/Updates
Table 48. Global Hepatitis B Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 49. Global Hepatitis B Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Hepatitis B Vaccines Average Price by Manufacturer (2018-2023) & (USD/Doses)
Table 51. Market Position of Manufacturers in Hepatitis B Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Hepatitis B Vaccines Production Site of Key Manufacturer
Table 53. Hepatitis B Vaccines Market: Company Product Type Footprint
Table 54. Hepatitis B Vaccines Market: Company Product Application Footprint
Table 55. Hepatitis B Vaccines New Market Entrants and Barriers to Market Entry
Table 56. Hepatitis B Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Hepatitis B Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 58. Global Hepatitis B Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 59. Global Hepatitis B Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Hepatitis B Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Hepatitis B Vaccines Average Price by Region (2018-2023) & (USD/Doses)
Table 62. Global Hepatitis B Vaccines Average Price by Region (2024-2029) & (USD/Doses)
Table 63. Global Hepatitis B Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 64. Global Hepatitis B Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 65. Global Hepatitis B Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Hepatitis B Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Hepatitis B Vaccines Average Price by Type (2018-2023) & (USD/Doses)
Table 68. Global Hepatitis B Vaccines Average Price by Type (2024-2029) & (USD/Doses)
Table 69. Global Hepatitis B Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 70. Global Hepatitis B Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 71. Global Hepatitis B Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Hepatitis B Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Hepatitis B Vaccines Average Price by Application (2018-2023) & (USD/Doses)
Table 74. Global Hepatitis B Vaccines Average Price by Application (2024-2029) & (USD/Doses)
Table 75. North America Hepatitis B Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 76. North America Hepatitis B Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 77. North America Hepatitis B Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 78. North America Hepatitis B Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 79. North America Hepatitis B Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 80. North America Hepatitis B Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 81. North America Hepatitis B Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Hepatitis B Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Hepatitis B Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 84. Europe Hepatitis B Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 85. Europe Hepatitis B Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 86. Europe Hepatitis B Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 87. Europe Hepatitis B Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 88. Europe Hepatitis B Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 89. Europe Hepatitis B Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Hepatitis B Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Hepatitis B Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 92. Asia-Pacific Hepatitis B Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 93. Asia-Pacific Hepatitis B Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 94. Asia-Pacific Hepatitis B Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 95. Asia-Pacific Hepatitis B Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 96. Asia-Pacific Hepatitis B Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 97. Asia-Pacific Hepatitis B Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Hepatitis B Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Hepatitis B Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 100. South America Hepatitis B Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 101. South America Hepatitis B Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 102. South America Hepatitis B Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 103. South America Hepatitis B Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 104. South America Hepatitis B Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 105. South America Hepatitis B Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Hepatitis B Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Hepatitis B Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 108. Middle East & Africa Hepatitis B Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 109. Middle East & Africa Hepatitis B Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 110. Middle East & Africa Hepatitis B Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 111. Middle East & Africa Hepatitis B Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 112. Middle East & Africa Hepatitis B Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 113. Middle East & Africa Hepatitis B Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Hepatitis B Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Hepatitis B Vaccines Raw Material
Table 116. Key Manufacturers of Hepatitis B Vaccines Raw Materials
Table 117. Hepatitis B Vaccines Typical Distributors
Table 118. Hepatitis B Vaccines Typical Customers
List of Figures
Figure 1. Hepatitis B Vaccines Picture
Figure 2. Global Hepatitis B Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hepatitis B Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Yeast Derived Examples
Figure 5. CHO Derived Examples
Figure 6. Global Hepatitis B Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Hepatitis B Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Children Examples
Figure 9. Adult Examples
Figure 10. Global Hepatitis B Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Hepatitis B Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Hepatitis B Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 13. Global Hepatitis B Vaccines Average Price (2018-2029) & (USD/Doses)
Figure 14. Global Hepatitis B Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Hepatitis B Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Hepatitis B Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Hepatitis B Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Hepatitis B Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Hepatitis B Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Hepatitis B Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Hepatitis B Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Hepatitis B Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Hepatitis B Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Hepatitis B Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Hepatitis B Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Hepatitis B Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Hepatitis B Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Hepatitis B Vaccines Average Price by Type (2018-2029) & (USD/Doses)
Figure 29. Global Hepatitis B Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Hepatitis B Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Hepatitis B Vaccines Average Price by Application (2018-2029) & (USD/Doses)
Figure 32. North America Hepatitis B Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Hepatitis B Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Hepatitis B Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Hepatitis B Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Hepatitis B Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Hepatitis B Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Hepatitis B Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Hepatitis B Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Hepatitis B Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Hepatitis B Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Hepatitis B Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Hepatitis B Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Hepatitis B Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Hepatitis B Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Hepatitis B Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Hepatitis B Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Hepatitis B Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Hepatitis B Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Hepatitis B Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Hepatitis B Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Hepatitis B Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Hepatitis B Vaccines Market Drivers
Figure 73. Hepatitis B Vaccines Market Restraints
Figure 74. Hepatitis B Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Hepatitis B Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Hepatitis B Vaccines
Figure 78. Hepatitis B Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
